Form 4: Sabra Health Care REIT Executive VP & CAO Jessica Flores Reports Stock Transactions

Sentiment:

SEC Form 4 Filing


Jessica Flores, Executive VP & CAO of Sabra Health Care REIT, reported the acquisition of 10,048 shares and the disposal of 4,085 shares to cover tax obligations on January 15, 2025.

Better than expectedThe vesting of stock units at 200% of the target indicates that the company's performance exceeded expectations relative to its peer group.

Summary

  • Jessica Flores, Executive VP & CAO of Sabra Health Care REIT, reported a transaction involving the company's common stock on January 15, 2025.
  • She acquired 10,048 shares of common stock through the vesting of stock units under the company's 2009 Performance Incentive Plan.
  • These stock units were tied to relative total stockholder return (TSR) and were granted on December 28, 2021 and February 9, 2022.
  • The Compensation Committee determined that the TSR units earned were 200% of the target, based on the company's performance relative to a peer group over a three-year period.
  • Additionally, 4,085 shares were disposed of to cover tax withholding obligations related to the vesting of the stock units.
  • After these transactions, Ms. Flores beneficially owns 72,118 shares of common stock, including 22,541 stock units that will be settled on a one-for-one basis in shares of the company's common stock.

Sentiment

Score: 7

Explanation: The document indicates strong performance leading to the vesting of stock units at 200% of the target, which is a positive sign. However, the disposal of shares for tax purposes is a neutral event.

Positives

  • The vesting of stock units at 200% of the target indicates strong performance relative to the peer group.
  • The acquisition of shares by a company executive can be seen as a positive sign of confidence in the company's future.

Negatives

  • The disposal of 4,085 shares, while for tax purposes, could be perceived negatively by some investors.

Risks

  • The value of the stock units is tied to the company's performance relative to its peers, which can fluctuate.
  • Changes in tax laws could impact the tax obligations related to stock unit vesting.

Industry Context

This filing is a routine disclosure of insider transactions, which is common in the real estate investment trust (REIT) sector. It provides transparency into the stock ownership of key executives.

Comparison to Industry Standards

  • The vesting of stock units based on total shareholder return is a common practice in the REIT industry to align executive compensation with shareholder value.
  • The 200% vesting of the target indicates that Sabra Health Care REIT has performed well compared to its peers over the three-year performance period, which is a positive sign for investors.
  • Other REITs such as Welltower (WELL) and Ventas (VTR) also use similar performance-based compensation structures for their executives.

Stakeholder Impact

  • Shareholders may view the vesting of stock units at 200% of the target as a positive sign of the company's performance.
  • The disposal of shares for tax purposes is unlikely to have a significant impact on stakeholders.

Key Dates

DateDescription
12/28/2021Date of grant of stock units subject to relative total stockholder return-based stock unit awards.
02/09/2022Date of grant of stock units subject to relative total stockholder return-based stock unit awards.
01/15/2025Date of stock acquisition and disposal by Jessica Flores.
01/17/2025Date of signature of the report.

Keywords

stock units, TSR, vesting, executive compensation, insider trading, Sabra Health Care REIT, stock ownership, performance incentive plan

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.